ES436613A1 - Un procedimiento para la preparacion de una composicion far-maceutica estabilizada. - Google Patents

Un procedimiento para la preparacion de una composicion far-maceutica estabilizada.

Info

Publication number
ES436613A1
ES436613A1 ES436613A ES436613A ES436613A1 ES 436613 A1 ES436613 A1 ES 436613A1 ES 436613 A ES436613 A ES 436613A ES 436613 A ES436613 A ES 436613A ES 436613 A1 ES436613 A1 ES 436613A1
Authority
ES
Spain
Prior art keywords
tertiary alcohol
series prostaglandins
alcohol stabilized
stabilized
series
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES436613A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES436613A1 publication Critical patent/ES436613A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES436613A 1974-04-19 1975-04-15 Un procedimiento para la preparacion de una composicion far-maceutica estabilizada. Expired ES436613A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
ES436613A1 true ES436613A1 (es) 1977-04-16

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES436613A Expired ES436613A1 (es) 1974-04-19 1975-04-15 Un procedimiento para la preparacion de una composicion far-maceutica estabilizada.

Country Status (23)

Country Link
US (1) US3927197A (es)
JP (1) JPS5337408B2 (es)
AR (1) AR213271A1 (es)
AT (1) AT348130B (es)
AU (1) AU470631B2 (es)
BE (1) BE828065A (es)
BG (1) BG35326A3 (es)
CA (1) CA1034044A (es)
CS (1) CS191244B2 (es)
DD (1) DD119131A5 (es)
DE (1) DE2516105C3 (es)
DK (1) DK138161B (es)
ES (1) ES436613A1 (es)
FI (1) FI62220C (es)
FR (1) FR2267760B1 (es)
GB (1) GB1474852A (es)
HU (1) HU175405B (es)
IE (1) IE40829B1 (es)
IL (1) IL46994A (es)
LU (1) LU72320A1 (es)
NL (1) NL158384B (es)
PH (1) PH11697A (es)
SE (1) SE428528B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
PT725642E (pt) * 1993-10-27 2000-05-31 Upjohn Co Prostaglandina e 1 estabilizada
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
MX2020008680A (es) 2018-02-21 2020-09-25 Ai Therapeutics Inc Terapia de combinacion con apilimod y agentes glutamatergicos.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
IL46994A0 (en) 1975-06-25
SE428528B (sv) 1983-07-11
FI751108A (es) 1975-10-20
IE40829L (en) 1975-10-19
CA1034044A (en) 1978-07-04
US3927197A (en) 1975-12-16
DE2516105B2 (de) 1981-01-08
FR2267760B1 (es) 1978-08-04
SE7503723L (sv) 1975-10-20
IL46994A (en) 1979-10-31
GB1474852A (en) 1977-05-25
FR2267760A1 (es) 1975-11-14
AR213271A1 (es) 1979-01-15
NL7504274A (nl) 1975-10-21
IE40829B1 (en) 1979-08-29
FI62220B (fi) 1982-08-31
PH11697A (en) 1978-05-24
DD119131A5 (es) 1976-04-12
AU7987775A (en) 1976-03-25
DE2516105A1 (de) 1975-10-23
DK138161C (es) 1979-01-02
JPS5337408B2 (es) 1978-10-09
BG35326A3 (en) 1984-03-15
HU175405B (hu) 1980-07-28
JPS50145515A (es) 1975-11-21
AU470631B2 (en) 1976-03-25
LU72320A1 (es) 1976-03-17
CS191244B2 (en) 1979-06-29
NL158384B (nl) 1978-11-15
DK138161B (da) 1978-07-24
BE828065A (fr) 1975-10-17
DK167075A (es) 1975-10-20
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15

Similar Documents

Publication Publication Date Title
ES436613A1 (es) Un procedimiento para la preparacion de una composicion far-maceutica estabilizada.
ZA756246B (en) Improvements relating to high-pressure gasification
CS181294B2 (en) Arrangement for gasification of slightly dispersed fuel
ZA754223B (en) Improvements relating to the gasification of solid fuel
AR205721A1 (es) Procedimiento de preparacion de alcoholes superiores de 16 a 22 atomos de carbono
AU501389B2 (en) Prostaglandin analogues
GB1554023A (en) Compositions containing prostaglandin lactones
AU497401B2 (en) Prostaglandin compositions
ES438652A1 (es) Un metodo para obtener una serie de compuestos 5-aril-2-fu- ramidinas.
GB1516181A (en) Cosmetic composition containing serine
AU7678474A (en) Prostaglandin analogues
AU8003775A (en) Prostaglandin analogues
ZA756628B (en) Prostaglandin analog ester
AU498732B2 (en) Gasification of carbon
ES443236A1 (es) Procedimiento para preparar 2-cloro-1,2, 2-trifluoretil-di- fluormetil-eter.
SU487098A1 (ru) Композици дл получени пенопласта
NZ179192A (en) Prostaglandin analogues and pharmaceutical compositions
ES438725A1 (es) Un procedimiento de preparacion de derivados sustituidos del acido prostanoico.
ES441003A1 (es) Un procedimiento para preparar productos intermedios utiles en la sintesis de prosglandinas.
GB1505695A (en) Unsaturated polymerizable ester composition
ES394667A1 (es) Procedimiento de preparacion de derivados del acido prosta-noico.
ZA732818B (en) Composition and process(prostaglandin analogs)
ES418888A1 (es) Procedimiento para la obtencion de amidas de esteres de acidos o-fenil-n-alquil (alquenil)-etanofosforicos.
AU8275975A (en) Prostaglandin analogs
AU502124B2 (en) Analogues of prostanoic acids